Bridge Biotherapeutics
Business Services · 11-50 Employees
View Company Info for Free
Overview
Website
www.bridgebiorx.comRevenue
$6.7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Bridge Biotherapeutics
Bridge Biotherapeutics Inc. is a publicly traded clinical-stage biotech company based in the Republic of Korea with offices in the U.S. and China. Founded in 2015, Bridge Biotherapeutics is engaged in the discovery and development of novel therapeutics for disease indications with high unmet medical needs including cancer, ulcerative colitis, and fibrotic diseases. The company's clinical pipeline includes BBT-401, a first-in-class Pellino-1 inhibitor for the treatment of ulcerative colitis; BBT-877, a novel autotaxin inhibitor for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis (IPF); and BBT-176, a potent targeted cancer therapy for non-small cell lung cancer (NSCLC) with C797S triple EGFR mutations. Entering 2022, the company enhances its strategic focus on fibrotic diseases and cancers.Explore more
Bridge Biotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bridge Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Bridge Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Bridge Biotherapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Bridge Biotherapeutics launches new products
Earning: See what the market has to say on Bridge Biotherapeutics recently announced quarterly report
Check if Bridge Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Bridge Biotherapeutics has new funding data
Website visits: Recent activity has been detected on your website
Check out if Bridge Biotherapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Bridge Biotherapeutics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Bridge Biotherapeutics
Compare insights from companies similar to Bridge Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bridge Biotherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bridge Biotherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bridge Biotherapeutics.
Bridge Biotherapeutics Tech Stack
A closer look at the technologies used by Bridge Biotherapeutics
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Bridge Biotherapeutics
Sign Up For FreeTo access detailed company insights
Bridge Biotherapeutics Inc. is a publicly traded clinical-stage biotech company based in the Republic of Korea with offices in the U.S. and China. Founded in 2015, Bridge Biotherapeutics is engaged in the discovery and development of novel therapeutics for disease indications with high unmet medical needs including cancer, ulcerative colitis, and f... Read More
